Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 293
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01626092 | Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders | ||
| NCT00176865 | Stem Cell Transplant for Immunologic or Histiocytic Disorders | ||
| NCT02661035 | Allo HSCT Using RIC for Hematological Diseases | ||
| NCT03365661 | QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML | ||
| NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | ||
| NCT03297463 | Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma | ||
| NCT01385423 | Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) | ||
| NCT00617929 | Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant | ||
| NCT01451502 | Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units | ||
| NCT01593618 | Empowering Cancer Survivors Through Information Technology | ||
| NCT00176826 | T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders | ||
| NCT01343368 | Preservation of Ovarian Function After Hematopoietic Cell Transplant | ||
| NCT06792825 | HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL | ||
| NCT01652092 | Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies | ||
| NCT04630769 | FT516 and IL2 With Enoblituzumab for Ovarian Cancer | ||
| NCT00095160 | Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors | ||
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | ||
| NCT00652899 | Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT03294304 | BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy | ||
| NCT00005987 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | ||
| NCT01885897 | IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT | ||
| NCT04928950 | Charcoal in Lung Cancer Patients Undergoing TEMLA | ||
| NCT02046291 | Safety of Romiplostim (Nplate®) Following UCBT | ||
| NCT02042924 | Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies | ||
| NCT02227797 | MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients | ||
| NCT01581970 | Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer | ||
| NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
| NCT06693986 | Adenovirus (RGDCRAdCOX2F) | ||
| NCT00818649 | Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia | ||
| NCT00176917 | Stem Cell Transplantation for Hurler | ||
| NCT00167167 | Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia | ||
| NCT00287911 | Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer | ||
| NCT00625092 | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | ||
| NCT03651037 | Physical Activity Platform to Improve Bone Health in Cancer Survivors | ||
| NCT04363346 | Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia | ||
| NCT01505569 | Auto Transplant for High Risk or Relapsed Solid or CNS Tumors | ||
| NCT05973656 | Role of Acetaldehyde in the Development of Oral Cancer | ||
| NCT02948062 | Early Diagnosis Of Childhood Cerebral ALD | ||
| NCT06342986 | Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT00303667 | Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | ||
| NCT02670837 | Study of Cellutome System for Treatment of Individual Lesions in EB Pts | ||
| NCT01099631 | IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread | ||
| NCT03383055 | CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig | ||
| NCT00619021 | Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer | ||
| NCT00618696 | Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia | ||
| NCT01033552 | Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs | ||
| NCT01634217 | Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation | ||
| NCT00376519 | Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases | ||
| NCT06584929 | Rural Smoking Cessation | ||
| NCT02500472 | Investigation of Kava Effects on NNK Metabolism |
